Tianjin Lisheng Pharmaceutical Co.,Ltd.
Shenzhen Stock Exchange 002393.SZ
Tianjin Lisheng Pharmaceutical Co.,Ltd. Price to Book Ratio (P/B) on January 14, 2025: 0.85
Tianjin Lisheng Pharmaceutical Co.,Ltd. Price to Book Ratio (P/B) is 0.85 on January 14, 2025, a -9.91% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
-
Tianjin Lisheng Pharmaceutical Co.,Ltd. 52-week high Price to Book Ratio (P/B) is 0.99 on May 09, 2024, which is 15.92% above the current Price to Book Ratio (P/B).
-
Tianjin Lisheng Pharmaceutical Co.,Ltd. 52-week low Price to Book Ratio (P/B) is 0.55 on July 24, 2024, which is -35.59% below the current Price to Book Ratio (P/B).
-
Tianjin Lisheng Pharmaceutical Co.,Ltd. average Price to Book Ratio (P/B) for the last 52 weeks is 0.81.
Key data
| Date | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield | Price to Earnings Ratio (P/E) |
|---|
Market news
Loading...
Shenzhen Stock Exchange: 002393.SZ
| CEO | Mr. Fujun Wang |
| IPO Date | April 23, 2010 |
| Location | China |
| Headquarters | No.16, Saida North 1st Road |
| Employees | 1,328 |
| Sector | Health Care |
| Industries | |
Description
Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the production and sale of chemical medicines. The company offers tablets, hard capsules, dripping pills, freeze-dried powder injections, water injections, and bulk medicines, as well as intermediates, diagnostic reagents, biochemical reagents, and plastic bottles. It also exports its products. The company is based in Tianjin, China. Tianjin Lisheng Pharmaceutical Co.,Ltd. operates as a subsidiary of Tianjin Pharmaceutical Holdings Co., Ltd.
Key trends
Past 5 years
Similar companies
Harbin Gloria Pharmaceuticals Co., Ltd
USD 0.34
5.49%
Zhejiang Xianju Pharmaceutical Co.,Ltd.
USD 1.34
1.98%
Jinghua Pharmaceutical Group Co., Ltd.
USD 1.01
2.22%
StockViz Staff
January 16, 2025
Any question? Send us an email